Incannex Healthcare Limited Common Stock
$3.64
$0.05 (+1.39%)
$3.42Day Range$3.72
Key Statistics
Market Cap
$43.55M
Shares Outstanding
12.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 25, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$3.58
Day High
$3.72
Day Low
$3.42
Volume
92.2K
VWAP
$3.62
Prev Close
$3.59
Transactions
--
Acc. Volume
--
About Incannex Healthcare Limited Common Stock
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
PHARMACEUTICAL PREPARATIONSSIC 283412 employees8 CENTURY CIRCUIT, NORWEST NSW61 409 840 786IPO Feb 25, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001873875
- Composite FIGI
- BBG01J0814Y2
- Share Class FIGI
- BBG01J0814Z1
- Ticker Root
- IXHL
- SIC Code
- 2834
About Incannex Healthcare Limited Common Stock (IXHL) Stock
Incannex Healthcare Limited Common Stock (IXHL) closed the 2026-09-18 session at $3.64, up 1.39% versus the previous close (+0.05). The stock opened at $3.58 and traded between $3.42 and $3.72 during that session. Session trading volume was 92K shares. The volume-weighted average price (VWAP) is $3.62.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Incannex Healthcare Limited Common Stock has a market capitalization of $43.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. IXHL is listed on the XNAS exchange. The company employs approximately 12 people. The recorded listing date is 2022-02-25.
On this page you can find market IXHL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.